You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

intrinsic subtype

Showing 1 - 25 of 1,214
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer Trial in Portugal, Spain (Ribociclib + Letrozole OR Fulvestrant, Palbociclib + Letrozole OR

Recruiting
  • Metastatic Breast Cancer
  • Ribociclib + Letrozole OR Fulvestrant
  • +2 more
  • Creixomil, Portugal
  • +44 more
Apr 1, 2022

Breast Cancer, Cancer of the Breast Trial in Saint Louis (VENTANA MIB-1 Ki67 assay, Oncotype DX® Recurrence Score, PAM50-based

Not yet recruiting
  • Breast Cancer
  • Cancer of the Breast
  • VENTANA MIB-1 Ki67 assay
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 18, 2023

Breast Cancer Trial in Sweden (Trastuzumab deruxtecan, Docetaxel, Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan
  • +9 more
  • Malmö, Sweden
  • +6 more
Jun 8, 2023

Metastatic Breast Cancer Trial in Spain (Palbociclib, Trastuzumab, Endocrine therapy)

Recruiting
  • Metastatic Breast Cancer
  • Badalona, Barcelona, Spain
  • +34 more
Oct 24, 2022

HER2-positive Breast Cancer, Invasive Carcinoma of the Breast, Breast Cancer Trial in United States (Pertuzumab+TRASTUZUMAB,

Recruiting
  • HER2-positive Breast Cancer
  • +5 more
  • Pertuzumab+TRASTUZUMAB
  • ADJUVANT ENDOCRINE THERAPY
  • Stamford, Connecticut
  • +21 more
Dec 12, 2022

Breast Cancer Trial in Boston, Ann Arbor (drug, procedure, radiation)

Active, not recruiting
Has Results
  • Breast Cancer
  • Boston, Massachusetts
  • +2 more
May 2, 2022

Prosigna Assay on Neoadjuvant Clinical Decision-making in

Recruiting
  • Breast Cancer
  • Prosigna PAM-50 assay
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Apr 5, 2022

Real-World Data of Clinicopathological Characteristics and

Recruiting
  • Early Breast Cancer
  • +2 more
    • Barcelona, Spain
    • +9 more
    Jan 18, 2023

    Breast Cancer Trial in Spain (Palbociclib, Letrozole)

    Recruiting
    • Breast Cancer
    • Barcelona, Spain
    • +7 more
    Sep 3, 2021

    EGFR Gene Mutation, Nonsmall Cell Lung Cancer Trial in Washington, Hackensack (Dasatinib, Osimertinib)

    Active, not recruiting
    • EGFR Gene Mutation
    • Nonsmall Cell Lung Cancer
    • Washington, District of Columbia
    • +1 more
    Jan 9, 2022

    Circulating miRNAs.

    Completed
    • Breast Cancer
    • +2 more
      • Cork, Ireland
      • +6 more
      Jan 4, 2022

      Breast Cancer Stage II Trial in France, Portugal, Spain (Ribociclib (neoadjuvant), Chemotherapy (adjuvant), Ribociclib

      Recruiting
      • Breast Cancer Stage II
      • Ribociclib (neoadjuvant)
      • +2 more
      • Avignon, France
      • +49 more
      Jul 7, 2022

      Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Stage II and

      Recruiting
      • Breast Cancer
      • Breast Cancer Stage II-III
      • Docetaxel- Carboplatin
      • Madrid, Spain
        Hospital Universitario Gregorio Marañon
      Aug 24, 2021

      High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

      Recruiting
      • High Grade Glioma
      • +12 more
      • LUTATHERA® (Lutetium Lu 177 dotatate)
      • Aurora, Colorado
      • +8 more
      Jan 16, 2023

      PTSD, Adolescent, Psychological Trauma Trial (TF-CBT, TAU)

      Not yet recruiting
      • PTSD
      • +2 more
      • TF-CBT
      • TAU
      • (no location specified)
      Jun 14, 2022

      Opioid Use Disorder, Behavioral Symptoms, Psychiatric or Mood Diseases or Conditions Trial (Remote Motivational Enhancement

      Not yet recruiting
      • Opioid Use Disorder
      • +2 more
      • Remote Motivational Enhancement (RME) Intervention Arm
      • Information Only
      • (no location specified)
      Apr 27, 2022

      ADjuvant chemotherAPy After Curative Intent resecTion of

      Recruiting
      • Ampullary Adenocarcinoma
      • Brescia, BS, Italy
        Fondazione Poliambulanza
      Oct 3, 2023

      Opioid Use Disorder, Moderate, Opioid Use, Opioid Dependence Trial (unilateral transcranial photobiomodulation)

      Not yet recruiting
      • Opioid Use Disorder, Moderate
      • +5 more
      • unilateral transcranial photobiomodulation
      • (no location specified)
      Aug 15, 2023

      Multiple Sclerosis Trial (a-tDCS)

      Not yet recruiting
      • Multiple Sclerosis
      • a-tDCS
      • (no location specified)
      Sep 24, 2022

      Neoadjuvant Chemotherapy Response in Invasive Breast Cancer

      Not yet recruiting
      • Breast Neoplasms
      • shear wave elastography
      • (no location specified)
      Dec 19, 2021

      Estrogen Receptor Negative, HER2/Neu Negative, Invasive Breast Carcinoma Trial in South Africa, United States (drug, other,

      Active, not recruiting
      Has Results
      • Estrogen Receptor Negative
      • +11 more
      • Mobile, Alabama
      • +1023 more
      Dec 7, 2022

      Flatfoot, Flexible Trial in Brugge (Foot muscle strengthening, Foot orthotics)

      Not yet recruiting
      • Flatfoot, Flexible
      • Foot muscle strengthening
      • Foot orthotics
      • Brugge, West Flanders, Belgium
        KU Leuven
      Apr 21, 2023

      Plantar Fasciitis, Chronic, Pain Trial in Sha Tin (targeted intrinsic foot muscle exercises)

      Recruiting
      • Plantar Fasciitis, Chronic
      • Pain
      • targeted intrinsic foot muscle exercises
      • Sha Tin, Hong Kong
        CUHK-ORT Sports Injury Research Laboratory
      Jul 8, 2022

      Flat Foot Trial (Foot exercise, Lower Extremity Exercise)

      Not yet recruiting
      • Flat Foot
      • Foot exercise
      • Lower Extremity Exercise
      • (no location specified)
      Sep 13, 2023

      Local Recurrence Following Breast Conserving Surgery and

      Active, not recruiting
      • Breast Cancer
        • Calgary, Alberta, Canada
        • +26 more
        Sep 19, 2022